test

Boxer Capital Management, LLC, by Aaron I Davis, Managing Member

@Boxer Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.038BTotal holdings68
Assets growth rate7.32%Assets growth rate (2-Q avg)0.55%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Boxer Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.

Assets under management

The assets under management (AUM) of Boxer Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.038B in assets, with a quarterly growth rate of 7.32% and a 2-quarter average growth rate of 0.55%. The portfolio is managed by Boxer Capital Management, LLC, by Aaron I Davis, Managing Member, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ORICOric Pharmaceuticals Inc
Recent Activity
0.88%
$17.759M
1.733M shares@ $10.26 avg price
GPCRStructure Therapeutics Inc
Recent Activity
0.87%
$17.556M
400,000 shares@ $43.89 avg price
FATEFate Therapeutics Inc
Recent Activity
Decreased -39.61%
0.86%
$17.363M
4.961M shares@ $3.5 avg price
ELVNEnliven Therapeutics Inc
Recent Activity
0.85%
$17.146M
671,358 shares@ $25.54 avg price
REPLReplimune Group Inc
Recent Activity
0.83%
$16.838M
1.536M shares@ $10.96 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
0.82%
$16.576M
1.19M shares@ $13.94 avg price
CGEMCullinan Therapeutics
Recent Activity
Increased 38%
0.75%
$15.198M
907,895 shares@ $16.74 avg price
ARVNArvinas Inc
Recent Activity
0.74%
$14.99M
608,614 shares@ $24.64 avg price
CLYMEliem Therapeutics Inc
Recent Activity
0.66%
$13.25M
2.603M shares@ $5.09 avg price
RLAYRelay Therapeutics Inc
Recent Activity
0.64%
$12.879M
1.819M shares@ $7.09 avg price